Compass Therapeutics CMPX
NASDAQ CMPX
$0.83 -0.01 (-0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Compass Therapeutics (CMPX) Debt Ratio (2018 - 2021)

Updated

Compass Therapeutics' Debt Ratio was 0.11 in Q3 2021, down 21.9% from the prior quarter.

Analysis

Compass Therapeutics (CMPX) Debt Ratio (2018 - 2021) Analysis & Trends

For FY2020, Debt Ratio at Compass Therapeutics came in at 0.18, down 63.5% from FY2019.

  • In earlier years, Debt Ratio was 0.49 in FY2019 and 1381.00 in FY2018.
  • The Q3 2021 figure marks the lowest quarterly Debt Ratio in data going back to Q1 2019.
  • Per Business Quant data, CMPX's Debt Ratio in the three quarters before Q3 2021 was 0.14 (Q2 2021), 0.16 (Q1 2021) and 0.18 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Compass Therapeutics 151.27 Mn -597.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 0.11
Jun 30, 2021 0.14
Mar 31, 2021 0.16
Dec 31, 2020 0.18
Sep 30, 2020 0.18
Jun 30, 2020 0.19
Mar 31, 2020 27.53
Dec 31, 2019 0.49
Sep 30, 2019 97.06
Jun 30, 2019 14.82
Mar 31, 2019 14.82
Dec 31, 2018 13.28
Sep 30, 2018 20.29
Jun 30, 2018 6.86
Mar 31, 2018 1,381.00
API Access

Compass Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CMPX&period=max&api_key=YOUR_API_KEY